We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+18.1%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.52B
AUM Growth
+$95.3M
Cap. Flow
-$53M
Cap. Flow %
-3.48%
Top 10 Hldgs %
46.4%
Holding
811
New
169
Increased
201
Reduced
172
Closed
223

Sector Composition

Rank Sector Weight
1 Healthcare 30.8%
2 Financials 24.54%
3 Technology 21.73%
4 Communication Services 4.41%
5 Energy 3.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VSTEW
301
DELISTED
Vast Renewables Limited Warrants
VSTEW
$38.3K ﹤0.01%
+382,471
New +$46.4K
VSEEW
302
DELISTED
VSEE HEALTH INC WTS 29
VSEEW
$38K ﹤0.01%
1,432,606
+1,055,734
+280% +$23.9K
MRDB.WS
303
DELISTED
MariaDB plc Warrants, each whole warrant exercisable for one Ordinary Share at an exercise price of $11.50 per share
MRDB.WS
$37K ﹤0.01%
924,457
+200
+0% +$12
SPKLW
304
Spark I Acquisition Corp Warrant
SPKLW
$7M
$36.8K ﹤0.01%
+306,504
New +$32.9K
PIIIW icon
305
P3 Health Partners Inc Warrant
PIIIW
$186K
$36.8K ﹤0.01%
350,947
+74,623
+27% +$9.04K
BTM
306
DELISTED
Bitcoin Depot
BTM
$32.3K ﹤0.01%
1,429
-466
-25% -$8.18K
KACLR
307
DELISTED
Kairous Acquisition Corp. Limited Rights
KACLR
$31.8K ﹤0.01%
434,231
+300
+0.1% +$32
SGHC icon
308
SGHC Ltd
SGHC
$6.59B
$31.7K ﹤0.01%
+10,000
New +$33.6K
VHAQ.RT
309
DELISTED
Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
$31.6K ﹤0.01%
526,475
+6,200
+1% +$350
HCMAW
310
DELISTED
HCM Acquisition Corp Warrant
HCMAW
$31.4K ﹤0.01%
1,166,800
+719,505
+161% +$16K
TE.WS
311
DELISTED
T1 Energy Inc Warrants
TE.WS
$30.8K ﹤0.01%
+154,200
New +$61K
CLRCR
312
DELISTED
ClimateRock Right
CLRCR
$30.5K ﹤0.01%
277,100
+100
+0% +$8
MAPSW
313
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$28.9K ﹤0.01%
+964,566
New +$64K
BLEUR
314
DELISTED
bleuacacia ltd Rights
BLEUR
$28.4K ﹤0.01%
568,567
-198,100
-26% -$8.4K
PORT.WS
315
DELISTED
Southport Acquisition Corporation Warrants, each exercisable for one share of Class A common stock at an exercise price of $11.50
PORT.WS
$27.8K ﹤0.01%
1,111,900
+505,772
+83% +$12.2K
CXAIW icon
316
CXApp Inc Warrant
CXAIW
$27.7K ﹤0.01%
+342,086
New +$31.5K
PNST.WS
317
DELISTED
Pinstripes Holdings, Inc. Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 per share
PNST.WS
$27.7K ﹤0.01%
75,000
-22,672
-23% -$4.18K
FOA icon
318
Finance of America Companies
FOA
$195M
$27.5K ﹤0.01%
2,500
BARK.WS
319
DELISTED
BARK Inc Warrants
BARK.WS
$27.4K ﹤0.01%
+400,938
New +$30.4K
CDROW icon
320
Codere Online Luxembourg Warrants
CDROW
$25.8K ﹤0.01%
+368,471
New +$30.3K
AERTW
321
Aeries Technology Warrant
AERTW
$887K
$25.4K ﹤0.01%
279,134
+160,222
+135% +$16.2K
ML.WS
322
DELISTED
MoneyLion Inc. Warrants, each whole warrant exercisable 1/30th of a share of Class A common stock at an exercise price of $345.00 per whole share
ML.WS
$25K ﹤0.01%
250,000
-337,455
-57% -$19K
IVCBW
323
DELISTED
Investcorp Europe Acquisition Corp I Warrant
IVCBW
$24.8K ﹤0.01%
108,110
+15,510
+17% +$3.13K
NVNIW
324
Nvni Group Limited Warrants
NVNIW
$24.7K ﹤0.01%
+676,012
New +$37.5K
GDSTR
325
DELISTED
Goldenstone Acquisition Limited Rights
GDSTR
$24.6K ﹤0.01%
370,064
-100
-0% -$10

Similar funds

Cowen and Company's Q4 2023 Portfolio in Review

As of Q4 2023, Cowen and Company held 811 positions worth $1.52B, up 6.7% from $1.43B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cowen and Company withdrew a net $53M in Q4 2023, closing 223 positions and reducing 172 holdings. Its most notable exit was AdvisorShares Pure US Cannabis ETF, an estimated $48.7M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 22% a quarter earlier, followed by Financials and Technology.

Against the trend, Cowen and Company opened a new position in Sage Therapeutics worth $29M.

  • Cowen and Company's largest Q4 2023 buy was Sage Therapeutics: 1,339,971 shares worth $29M.
  • Cowen and Company added most to PTC Therapeutics in Q4 2023, an estimated $66.9M increase.
  • Cowen and Company's biggest Q4 2023 reduction was Nabors Energy Transition Corp II, cutting an estimated $16.9M.
  • Cowen and Company fully exited AdvisorShares Pure US Cannabis ETF in Q4 2023, selling an estimated $48.7M.
  • Cowen and Company's ten largest holdings make up 46% of its $1.52B portfolio in Q4 2023.
  • Cowen and Company opened 169 new positions and closed 223 in Q4 2023.
  • Cowen and Company's portfolio value rose 6.7% quarter-over-quarter to $1.52B.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.